Yearly Archives: 2011

Cambridge, UK. Wednesday, 16 November 2011 – Oval Medical Technologies Ltd., (“Oval”) the pioneering autoinjector development company, today announced that they have successfully completed a £2 million investment from AptarGroup, Inc. (NYSE: ATR) (“Aptar”) . Additionally, Aptar has become Oval’s … Continue reading →

Cambridge, UK. The autoinjector development company Oval Medical Technologies ltd, has today announced further expansion with two new appointments of a Programme Manager and a Design Engineer. Alison Kwok joins the company in the capacity of Programme Manager from Owen … Continue reading →

Cambridge, UK. Oval Medical Technologies Ltd., the company developing the next generation of autoinjector technology, announced today that they have entered into two deals with pharmaceutical companies who are putting Oval’s primary drug containment technology through feasibility trials. Oval’s CEO … Continue reading →

Cambridge, UK. 10th January 2011. Oval Medical Technologies Ltd., the Cambridge based autoinjector company today announced results from two user studies in which Oval’s novel, proprietary autoinjector clearly demonstrated superiority compared with two well-known autoinjector devices currently on the market. … Continue reading →

Cambridge, UK – January 6th 2011. Oval Medical Technologies Ltd, the company developing the next generation of autoinjectors, announced that it successfully completed a second oversubscribed funding round. This was again led by The Cambridge Angels, with participation from Cambridge … Continue reading →